THE RELATIVE SIGNIFICANCE OF GRADED IMMUNIZING AND CHALLENGE DOSES IN MEASURING THE POTENCY OF VACCINES : A STUDY OF MOUSE PROTECTION BY TYPHOID VACCINE by Batson, H. C.
THE  RELATIVE  SIGNIFICANCE  OF  GRADED  IMMUNIZING 
AND  CHALLENGE  DOSES  IN  MEASURING  THE 
POTENCY  OF  VACCINES 
A  STUDY OF MOUSE PROTECTION BY TYPHOID VACCINE 
BY H. C. BATSON, PH.D. 
(From the Department of Biologic Products, Army Medical Department Research and 
Graduate School, Army Medical Center, Washington, D. C.) 
(Received for publication, March 5, 1949) 
Many of the difficulties encountered in measuring, quantitatively, the degree 
of resistance (immune response) developed in an individual animal or in groups 
of animals in response to an antigenic stimulus have been presented and dis- 
cussed at  considerable length by Wilson and Miles  (I). While the nature  of 
these  difficulties  has  not  been  clearly understood,  their  existence has been 
common knowledge to laboratory workers faced with the practical problem of 
evaluating the potency of an antigenic substance such as typhoid vaccine. In 
an attempt to develop an assay procedure of greater reliability, a comprehen- 
sive study of the sources of variation in potency tests of typhoid vaccine has 
been  undertaken  by the  Department  of  Biologic  Products,  Army Medical 
Department Research and Graduate School. This report of the relative signifi- 
cance of graded immunizing  and challenge  doses in mouse-protective potency 
tests is the first of a series of reports of the results of the study. 
Until relatively recently the potency of typhoid vaccine, in lieu of a  more 
meaningful method, was expressed in terms of its ability to produce agglutinins 
in rabbits following parenteral administration  of the product. The validity of 
results obtained in this manner has been questioned repeatedly. The agglutinin 
response as measured was primarily of the anti-H  type, and various workers 
(2,  3)  early reported  that  there  was essentially no  correlation  between the 
ability of a typhoid vaccine to protect  experimental  animals  and  its content 
of flagellar antigen. 
As a  consequence  of  the  above, recent  emphasis has been placed on the 
development of assay methods based directly on the ability of typhoid vaccines 
to protect animals against lethal doses of the test organism, Salmonella typ~sa. 
Such a test, using mucin to enhance the invasiveness of challenge  cultures (4) 
and mice as test animals, was developed by Siler and his coworkers (5) as an 
aid to the  selection of strains  of superior immunogenic  potency for vaccine 
production.  Shortly afterward,  the National Institute  of Health  (6) adopted 
as an official potency test for typhoid vaccine an active-immunity mouse-protec- 
tion test. More recently, Griffitts (7) has proposed a similar procedure which he 
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considered minimized certain sources of experimental variation, and Luippold 
(8) has proposed a procedure which incorporates an expression of the protective 
potency in terms of an absolute unit, the T.I.U. (Typhoid Immunogenic Unit). 
The above mentioned mouse-protection tests developed for estimating the 
potency of typhoid vaccine have been based on the survival (or mortality) rates 
in groups of mice given either,  (a)  graded immunizing doses and a  constant 
challenge dose or, (b) a constant immunizing dose and graded challenge doses. 
In either case the objective has been to obtain a  graded degree of response 
(survival or death) in successive groups of mice which would permit the calcula- 
tion of a  numerical expression of protective potency. Of the aforementioned 
procedures, that proposed by Luippold (8) was based on graded immunizing 
doses and a constant challenge dose, while the others (5-7) were based upon a 
constant immunizing dose and graded challenge doses. In each case the selection 
of the factor to be varied, the immunizing dose or the challenge dose, apparently 
was decided arbitrarily. 
The lack of agreement as to which factor should be varied and which should 
be held constant is not peculiar to the assay of typhoid vaccines. Comparable 
differences of opinion also exist in relation to the assay of cholera and pertussls 
vaccines. In most instances factual information regarding the accuracy and 
reproducibility of the results obtained by the two methods which would permit 
a logical selection of either method has been lacking. However, Kendrick a  al. 
(9) recently reported that the use of graded immunizing doses and a  constant 
chaUenge dose in the assay of pertnssis vaccine yields results superior to those 
obtained by the reverse procedure. 
It was the objective of the study reported here to determine, experimentally, 
the relative effect of graded immunizing and challenge doses on the degree of 
gradation in response in successive groups of actively immunized mice and to 
determine, if possible, which variable should logically be made the basis of an 
assay procedure. 
Materials and Metkods 
Standard Typhoid Va~dne.--The vaccine used in this study was a lyopMl~zed  monovalent 
typhoid vaccine  prepared from a suspension of S. typhosa, strain 58,  x produced by the method 
routinely used by the Army Medical Department Research and Graduate School  (10). Imme- 
diately before use the dried product was rehydrated with sterile distilled water and appro- 
priate dilutions were prepared with sterile physiological  safine so that the desired quantities 
were contained in 0.5 ml. volumes. 
Test M/xg.--White Swiss mice (Bagg strain) weighing 14 to 16 gin. were assigned to jars 
in groups of five at random except for sex. The assignment of groups of mice to blocks of the 
experiments, the location of the jars in the room, and the order of injection of mice by groups 
were all decided by random selection. The temperature of the mouse room was maintained at 
81  ° -4- I°F. 
x  For a full description of the strains of S. typhosa used in production of vaccine and for 
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Challenge Suspensions.--Challenge suspensions  containing  approximately  the  desired 
number of viable organisms were prepared by serial dilutions from veal infusion broth cultures 
of S. typhosa, strain 63, incubated at 37°C. for 16 hours. Final dilutions were made in 5 per 
cent mucin, so that the desired challenge doses were contained in 0.5 ml. volumes. Immedi- 
ately before use the challenge suspensions were diluted in sterile physiological  saline and nine 
1 ml. aliquots of suitable dilutions were plated to provide a check on the actual content of 
viable organisms. Challenge suspensions were all injected within 2 hours of preparation. 
Immunization and  Challenge Procedure.--Vaccine dilutions  and  challenge  suspensions 
were both injected intraperitoneally, the interval between injections being 6 days. The period 
of observation following challenge was 72 hours. 
Statistical Analysis.--The  nature of the experiments reported here suggested  that  the 
analysis of variance (11) would be an appropriate method for testing the significance of the 
sources of variation studied. By this procedure it is possible to estimate the portions of the 
total variation in the data contributed by each known source and also the residual variation 
or experimental error. 
Snedecor  (12) has pointed out that percentages based on small numbers of individuals 
are not suitable for this type of analysis unless some transformation of the data is employed. 
Statistical analyses of the data using either the probit (13) or the angle (14) transformation 
have yielded essentially the same results. Since in many instances in this study dosage- 
mortality (or dosage-survival) curves have been calculated by the Bliss (15) method employing 
probits, this transformation has been adopted throughout. 2 In those instances where 0 or 
100 per cent of the group died, probit values have been assigned arbitrarily as though one- 
fourth individual had died or survived as suggested by Bartlett (16). 
In certain instances it has been considered  desirable to express the standard errors of 
EDr0 values in terms of per cent of the EDr0. In these cases the standard errors have been 
approximated by the method proposed by Miller and Tainter (17). 
Selection of Immunizing- and Challenge-Dose Levels 
It was deemed essential to this investigation that the range of the progres- 
sively increased immunizing and challenge doses employed should be such as to 
insure that statistically significant different degrees of response  (mortality or 
survival) would be elicited. 
Even a  large difference in response in groups treated differently does not in- 
sure that the difference will be significant since marked differences in response 
in groups treated alike also are commonly observed. The proper evaluation of 
the significance of differences in response in groups treated differently is based 
on the ratio of this difference (between groups) to the difference in response in 
groups treated alike (within groups). 
Precision in the estimation of differences between and within groups can be 
increased by making multiple observations. Thus it was considered that experi- 
mental efficiency would be gained by making multiple observations at each of 
a  limited  number  of  immunizing-dose,  chaUenge-dose levels  rather  than  by 
making fewer observations at each of a larger number of levels. This necessitated 
2 Tables for the transformation of percentages  to probits have been provided by Bliss 
(15) and by Finney (19). Weiss (21) has prepared a chart which permits a direct transfor- 
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careful selection of the dosage levels to be employed. Accordingly,  preliminary 
experiments were conducted to determine the approximate fold increments of 
dosage required to insure significantly  different responses with each variable. 
Significantly  Different Challenge Dose Levels.- 
Twelve groups of five mice each, six groups of males and  six of females, were immunized 
with 0.01  ml. of standard typhoid vaccine made up to 0.5 mi. with physiological saline. Six 
days later all mice were challenged with S. typhosa, strain 63, suspended in 5 per cent mucin. 
Challenge doses of approximately 100, 500, 1000, 5000, 10,000,  and 50,000 viable organisms 
were given to each of one group of males and one group of females. The virulence of the 
challenge culture used was checked by injecting four groups of five normal mice each with 
the challenge suspension diluted in 5 per cent mucin so as to contain approximately 10 organ- 
isms per 0.5 ml. dose.  1 
TABLE  I a 
Mortality of Mice Immunized  with 0.01 ml.  Vaccine and  Challenged with Graded Doses of 
S. typhosa, Strain 63 
(Deaths/Total) 
Sex 
100 
Female.  2/5 
Male ..........  0/5 
Totals .......  2/10 
Challenge dose 
(Viable organisms  in 0.5 ml. of 5 per cent mucin) 
5OO 
1/5 
2/5 
3/lO 
lOOO 
3/5 
3/5 
6/lO 
5OO0 
3/5 
4/5 
7/10 
4/5 
4/5  I 
8/lO 
so,~ 
4/5 
5/5 
9/10 
To~ls 
17/3o 
18/3o 
35/6o 
Non-Immunized Controls (Challenge Dose, 10 Organisms) 
Deaths/Total 
Female .......  i  4/5  [  2/5 
Male .........  2/5  2/5 
TABLE  I b 
Probit Values Corresponding to Mortality Data Presented in Table I a 
Sex 
Female 
Male. 
Totals. 
Means... 
10o 
4.75 
3.36* 
8.11 
4.06 
Challenge dose (Viable  organisms) 
500 
4.16 
4.75 
8.91 
4.46 
lOOO 
5.25 
5.25 
10.50 
5.25 
5000  10,000 
5.25  5.84 
5.84  5.84 
11.09  11.68 
5.54  5.84 
50,000 
5.84 
6.64* 
12.48 
6.24 
Totals 
31.09 
31.68 
62.77 
5.23 
* Assigned values, cf. Bartlett (16). 
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values corresponding to the percentage of deaths in each group are presented in 
Tables I a and I b. 
The general significance of the differences in response to the different chal- 
lenge dose levels was determined by means of analysis of variance as given in 
Table II. 
As shown in Table II, the differences in response of groups of immunized mice 
to challenge doses ranging from 100 to 50,000 organisms were not sufficiently 
great to reach the 5 per cent level of significance, or, in other words, results such 
as these could have been expected to occur by chance alone more often than 
once in twenty trills. S It is difficult to accept that the incidences of death pro- 
TABLE  II 
Analysis  of Variance of Preliminary  Graded Ckallenge-Dose Constant Immunizing-Dose 
Probits-Mortality Data (Table I b) 
Source of variation 
Between doses (CD). 
Between sexes (S)... 
Error... 
Fotal  11 
Mean square 
1.3892 
0.0290 
0.3210 
Variance ratio  (F) 
4.33~ 
Not significant at 5 per cent level 
gressively increased from ~  to  -~ are  not  significant. Actually the  lick  of 
significance is more  apparent than  real. The correlation of probits-mortality 
with log-challenge dose was highly significant (r =  0.88; p  <  1 per cent) but 
the data were too meager and the challenge doses selected were insufficiently 
different in size for the demonstration of significance by analysis of variance. 
Also, the error mean square was relatively large and, therefore, a  larger mean 
square for differences between mean group responses to the graded challenge 
doses would be required for a significant value of F, the variance ratio. 
The nature of the error  term in the statistical analysis of this experiment 
merits further consideration. This estimate of error is not true experimental 
error; i.e., it is not an estimate of differences in response of comparable groups 
treated alike. Rather, it is an estimate of the discrepance in response of the two 
sexes to the various challenge doses. Such discrepance is commonly referred to 
s In this and the succeeding tables presenting analysis of variance, tests of significance 
(variance ratios) are the ratios of the mean squares for the factors of interest to the appro- 
priate error mean squares.  Mean squares are obtained by dividing the sums of squares of 
deviations from the grand mean by the corresponding degrees of freedom. Tables of variance 
ratios required for various levels of significance such as 5 per cent, 1 per cent, and 0.1 per cent 
are readily available (12, 22). These levels of significance correspond to probabilities of chance 
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as interaction and the latter term is employed throughout this report. Since 
both sexes of mice were used in this preliminary experiment, this interaction is 
the proper error term for testing the significance of the differences in response 
to the graded challenge doses. 
The objective of this preliminary experiment was to estimate the least differ- 
ence between mean group mortalities which would be significant and, in turn, 
to estimate the increases in chaUenge doses required to produce these differences 
in mortality. The least significant difference between mean group mortalities 
can be estimated by means of the equation 
~  =  ~.o~  ~  +  (1), 
where: LS~ is the least significant difference between mean group mortalities; 
t0.05 is the 5 per cent  significance level value of "t" (11)  with degrees of free- 
dom equal to those of the error mean square, a~; and nl and n2 are the number 
of observations  (groups of mice) upon which are based the two group means 
being compared. 
Applying this formula to the data obtained, the estimated least significant 
difference between means expressed in probits is 
LS~ =  2.57 ~¢/0.-~10 =  1.45 probits  (2) 
Thus  if a  particular  challenge  dose  caused  a  mortality  corresponding  to 
probits 5 (50 per cent), the least significantly different probits-mortality wouM 
be  1.45  probits  greater  or  less  than 5.  These significantly different probits- 
mortalities of 6.45 and 3.55 correspond to mortalities of 92.5 per cent and 7.5 
per cent, respectively. 
The differences in mortality required for significance, as calculated above, 
are  so great  that  they obviously would be diflScult  of close achievement in 
practical experimentation since they approach the absolute limits of the range 
of possible results, 0 and 100 per cent. 
The magnitude  of differences required for significance appears  even more 
dramatic when expressed in terms of the challenge doses estimated to effect 
' This equation is derived from the equation used for testing the significance  of differences 
between group means (12) 
where *~a, the variance of the difference  of the means, is equal to the sum of the variances 
of the means 
--  ~O-| 
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these mortality rates. The dosage-mortality equation calculated from the corn- 
billed data in Table I b by the method proposed by Bliss (15)  is 
17 =  3.0580 +  0.6625 X  (3) 
where  ~z is the  expected mortality in probits and X  is the  logarithm of the 
challenge dose. The challenge doses required to effect mortality rates of 50 per 
cent and rates significantly greater or less than 50 per Cent can be estimated 
by Equations 2 and 3 to be as follows :-- 
Mortality  Estimated dose (organisms) 
#ee cent 
7.5  6 
50.0  854 
92.5  132,000 
The errors inherent in the above method of estimation are quite large and the 
predicted challenge doses are of value primarily in depicting the relative magni- 
tude of such doses required to effect significantly different mortality rates. 
It was foreseen that  significant differences in mortality could be expected 
with  a  narrower range of challenge  doses by testing  these  concomitantly in 
multiple groups of mice. Thus if each challenge dose was tested in four groups 
of mice immunized with 0.01 ml. of vaccine and the estimate of error remained 
the same as above (Table II), the calculated least significant difference between 
means would be 0.73  probits  ~ and significantly different mortalities could be 
expected with consecutive challenge doses of approximately 63, 850, and 10,000 
organisms. Thus under the latter conditions a  twelve- to thirteenfold increase 
between successive challenge doses should  be sufficient to insure  significantly 
different mortality rates in immunized mice. 
Significantly Different  Immunizing Dose Levels.- 
Determination of the approximate progressive increases in graded immuniz- 
ing doses required  to establish significantly different  degrees of resistance of 
groups of mice to  a  constant  challenge  dose  was  approached  in  a  manner 
similar to that described above for graded challenge doses. 
Ten groups of five mice each, five  groups of females and five groups of males, were immu- 
nized with progressively graded quantifies of standard vaccine. Immuni~ng doses of 0.005, 
0.01, 0.025, 0.05, and 0.1 ml., in each case made up to a constant volume of 0.5 ml. with physio- 
logical saline, were each given to one group of females and one group of males. Six days later 
all mice were challenged with approximately 1000 viable S. typhosa, strain 63, suspended in 
0.5 ml. of 5 per cent mudu. 
6 The values of nz and ~v2 in Equation 1 would each be 4 and the  least significant difference 
between group means would be calculated as follows: 
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The number of survivors in each group after  72 hours and empirical probit 
values corresponding to the percentage of survival in each group are presented 
in Tables IIIa  and III b. 
The analysis of variance of the probits-survival data is presented in Table IV. 
TABLE III a 
Survival of Mice Gieen Graded Doses of Vaccine and Challenged with 1000 S. typkosa, 
Strain 63, in 5 per cent Mucin 
(Survival/Total) 
Sex 
Female .................. 
Male .................... 
Totals ................ 
Vaccine dose 
(ml. in O.S ml.) 
0.005 
1/5 
1/5 
2/10 
0.01 
3/5 
1/5 
4/10 
0.025 
4/5 
3/5 
7/10 
0.05 
5/5 
4/5 
9/lO 
0.1 
T  m 
5/5 
lO/lO 
Totals 
18/25 
14/25 
32/50 
Non-Immunized Controls (Challenge Dose, 10 Organisms) 
Desths/Total 
Female ..... iii  2/5  1/5 
Male .....  4/5  2/5 
TABLE III b 
Probit Values Corresponding to Survival Data Presented in Table III a 
Sex 
Female .... 
Male ..... 
Totals. 
Means. 
Vaccine dose (nil.) 
0.005  0.01 
4.16  5.25 
4.16  4.16 
8.32  9.41 
4.16  4.70 
0.025 
5.84 
5.25 
11.09 
5.55 
0.05 
6.64* 
5.84 
12.48 
6.24 
Totals 
0.1 
6.64*  28.53 
6.64*  26.05 
13.28  54.58 
6.64  5.46 
* Assigned values, yr. Bartlett  (16). 
The differences in mean survival rates in the groups of mice given progres- 
sively increased doses of vaccine were highly significant, the odds against chance 
occurrence of these results being greater than 100 to 1. This high degree of sig- 
nificance was due partly to the actual differences in survival and, also, to the 
relatively small mean square for error. As was pointed out in the discussion of 
Table II, this again is not a true measure of error but is an interaction, in this 
case the interaction between immunizing dose and sex. The actual difference in H.  C.  BATSON  241 
survival of the two sexes, although considerable, proved not to be statistically 
significant and as this difference was relatively consistent the interaction mean 
square was small. 
The least significant difference between group means was calculated to be 
0.96 probit. By inspection of the group means in Table III b it can be seen that 
the differences between the means of the groups given 0.005 and 0.025 ml. of 
vaccine  and, also of those given 0.01 and  0.05 ml., exceed 0.96  probit. The 
difference in immunizing doses given these pairs of groups was fivefold in each 
case. 
A better prediction of the relative size of immunizing doses required to effect 
significantly different survival rates can be made by means of the equation of 
the  dosage-survival  curve in  the  manner previously described in predicting 
significantly different challenge doses.  For calculation of the dosage-survival 
TABLE IV 
Analysis  of  Variance  of  Preliminary  Gradat  Immunizing-Dose  Constant Challenge-Dos, 
Probits-Surriral Data (Table HI b) 
Source of variation  Degrees of  Mean square  Variance ratio 
freedom  (F) 
Vaccine dose (VD)  ..................  4  2.1340  18.04"* 
Sex (S) ............................  1  0.6151  5.19~ 
Error ..............................  4  0.1183 
Total ............................  9 
** Ezceech 1 per cent level of significance. 
Not significant at 5 per cent level. 
curve the vaccine doses were first multiplied  by 1000  to obviate the  use of 
negative logarithms and the equation was calculated by the method of Bliss. 
The final prediction equation is as follows :-- 
1~" =  2.543 -t- 2.210 X  (4) 
where Y is the expected survival in probits and X  is the log of 1000 times the 
vaccine dose estimated to elicit this degree of protection. By the use of this 
equation the approximate doses of vaccine predicted to effect 50 per cent sur- 
vival and survival rates significantly less or greater than 50 per cent are as 
follows:-- 
Survival  Estimated dose 
per cent  ral. 
17  0.005 
50  0.013 
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Thus it was predicted  that significantly different survival rates  could be  ob- 
tained using approximately threefold increments in successive doses of vaccine 
even though only two groups of mice, one group of males and One of females, 
were used at  each immunizing dose level.  This  is  in sharp  contrast  to what 
could be expected using graded challenge doses and a constant immunizing dose. 
Direct Comparison of the Effect of Graded Immunizing and Challenge Doses 
It was realized that in any biological experiment,  the individuals  or groups 
observed may be subject to variation from many unrecognized sources. To in- 
sure a valid comparison of the effects of graded immunizing doses and challenge 
doses, a  factorial experiment was conducted which permitted  the  calculation 
of the effect of the two variables from the same groups of mice. 
Since it was estimated  from the preliminary experiments  that approximately twelve- to 
thirteenfold  progressive  increases  in  challenge doses would  be  required  for significantly 
different results at one immunizing dose level, it was expected that even greater fold increments 
might be required when applied at more than one immunizing dose level. Accordingly it was 
decided to use challenge doses increased by twentyfold increments.  The doses selected were 
50, 1000, and 20,000 organisms. In a similar manner it was decided to use immnni~ng doses 
progressively increased by fourfold increments.  The doses of vaccine selected were 0.003125, 
0.0125, and 0.05 mi. Finally, in order to obtain  a high precision in  estimating  error, each 
possible combination of vaccine dose and challenge dose was tested in six groups  of ten mice 
each,, three groups of females and three groups of males, 
The experiment was conducted in three parts,  at each time one group each 
of females and males being  tested  at each challenge-dose,  vaccine-dose level. 
The results of the three experiments were found not to differ significantly and 
the combined results, in terms of actual survivors and probits-survival I are pre- 
sented in Tables V a  and V b. 
The probits-survival  data  in Table V b were analyzed by analysis  of vari- 
ance.  e The analysis is presented in Table VI. 
The complete analysis of variance presented in Table VI confirms, in general, 
the conclusions drawn from the preliminary experiments.  The error term used 
for testing the significance of the interactions  is the true error term; i.e.,  it is 
based on the differences in survival of comparable groups treated alike. 
The only interaction found to be significant was that between the linear effect 
of challenge dose and sex. This indicates a lack of consistency in survival of the 
two sexes at the different challenge dose levels. This is readily confirmed by an 
inspection of the original data in Table V a, where it is shown that more males 
than females survived the challenge dose of 50 organisms, survivals were essen- 
6 At the suggestion of Dr. A. E. Brandt (23), the original data in terms of actual survivors 
(Table V a), were analyzed independently  by the factorial x 2 method  (11, 24). The results 
were essentially identical with those obtained by analysis of variance of the data transformed 
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TABLE V a 
Surd~al of Mice Given Graded Immunizing Doses o  ¢ Standard  Typhoid Vaccine and Graded 
Challenge Doses of S. typhosa, Strain 63, in 5 per cent Mudn 
(Survivors/Total) 
Challenge  dose  Sex 
F 
50  M 
F 
I000  M 
F 
20,000  M 
Vaccine dose 
(ml. in 0.5 ml.) 
0.003125  0.0125 
7/10  5/101 6/10 
5/lO] 8/lOl 7/lO 
2/1o  I 4/101 7/10 
5/10  / 6/101 4/10 
4/10  5/101 3/10 
2/10  3/101 1/10 
0.05 
lO/lO lO/lO 9/101 
8/lo  lO/lO  9/lO[ 
7/10]  7/101 9/10 
8/10  8/101 7/10 
7/10  9/101 7/10 
6/10  6/101 5/10 
2/lO  3/lOT 1/lO 
4/101 3/10, 4/101 
1/lO  / 1/lOl 2/lO 
1/lO  I 1/lOl 1/lO 
2/lO  / 0/101 2/10 
1/lO / O/lOl 1/lO 
Totals 
53/90 
58/90  111/180 
40/90  I  41/90  81/180 
39/90 
25/90  64/180 
Totals .......  30/180  84/180  142/180  256/540 
Non-Immunized Controls (Challenge Dose, 10 organisms) 
Deaths/Total 
F ..........  1 4/5]5/5J3/512/5  2/5 [ 4/5 
M  .........  S/S  I/5  4/5  I/5  2/5  2/5 
TABLE V b 
Probil Values Corresponding to Survival Data Presented in Table V a 
Challenge dose 
50 
1000 
20,000 
Sex 
Vaccine dose (ml.) 
0.003125 
F  4.16~4.48 3.72 
M  4.754.48  4.75 
F  L72 3.72  4.16 
M  3.723.72  3.72 
F 
M 
4.16 3.03" 14.16 
3.72 3.03*  13.72 
0.0125  I  0.05 
I 
5.52 5.00 5.25 6.96* 6.96'!6.28 
5.00 5.845.52 5.84  6.96* 6.28 
i 
4.164.755.525.52  5.52  6.28 
5.005.254.755.84  15.84 5.521 
I 
4.75 5.00,4.48 
4.164.48 3.72 
I 
5.52  5.28  5.52 
5.25  5.25  5.00 
Totals 
48.33 97.75 
49.42 
43.35 86.71  43.36 
!42.90 
138.33 81.23! 
5.4 
4.8 
4.5 
Totals..  70.92  88.15  106.62  265.69 
Means.  3.94  4.90  5.92  4.9 
* Assigned values, cf. Bartlett (16). 
tially equal at the challenge dose level of 1000 organisms, but more females than 
males survived the challenge dose of 20,000 organisms. Aside from any bio- 244  GRADED I~M'U'NIZING AND CHALLENGING DOSES 
logical implications, this observation is of interest in that it makes difficult the 
proper interpretation of the effect of the graded challenge doses. If the mean 
square of differences between groups treated alike is used as the error term, the 
linear effect of the graded challenge doses is highly significant. However, since 
the interaction CD~.  ×  S  proved to be significant, we must, on the basis of 
available evidence, assume that such an interaction actually exists and thus 
this interaction mean square becomes the proper error term for testing the 
significance of the linear effect of the graded challenge doses. The practical 
TABLE VI 
Analysis  of  Variance  of Graded Imraunizing-Dose  Graded Challenge-Dose Probits-Survinal 
Data (Table V b) 
Source of variation 
Main effects 
Vaccine dose, linear (VDL)... 
Vaccine dose, quadratic (VDo) 
Challenge dose, linear (CDL) 
Challenge dose, quadratic (CDo) 
Sex  (S). 
First ord~ interactio~ 
CDL X S. 
All others. 
~igher order interactions 
Error 
Degrees of freedom 
4 
36 
Mean square 
35.4025 
O. 0142 
7.58O9 
O. 2862 
0.2230 
O. 8899  5.89* 
None significant 
None significant 
0.1511 
Total.  53  I 
Variance ratio (F) 
234.29"** 
8.52~ 
*** Exceeds 0.1 per cent level of significance. 
Not significant  at 5 per cent level  in respect to proper error term (CDr, X S). 
* Exceeds 5 per cent level of significance. 
interpretation of the above is that it is impossible, from these data,  to draw 
general conclusions regarding the significance of the effect of graded challenge 
doses when the responses of both sexes of mice are considered. 
The test of significance of the linear effect of graded immunizing doses was 
less dii~cult since none of the interactions involving vaccine doses was signifi- 
cant. 
Although the differences in response to  doses  of vaccine progressively in- 
creased by fourfold increments were of far greater significance than were those 
to challenge doses increased by twentyfold increments, it is difficult to express 
the relative effectiveness of the  two variables in absolute  terms. This is es- l:I.  C.  BATSON  245 
pecially true since the degree of the effect of graded challenge doses was found 
to be dependent upon the sex of the mice. 
The effectiveness of the  two individual variables  employed concomitantly 
is best expressed by means of a  multiple regression equation (18,  19) relating 
probits-survival to log-challenge dose and log-immunizing dose. Since the effect 
of graded challenge doses was  found dependent upon sex,  separate multiple 
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/~/  •  - ....  Expected  survivol, femotes 
= Expected  Survival,moles 
I  I  J 
5  6  7  8  9 
LOG-(CHALLENGE DOSE X I000)+LOG-(IMMUNIZING  DOSE X  I000) 
FzG. 1. Probit-planes representing the  relationship between expected prohits-survival, 
log-(challenge  dose X I000), and log-(immunizing  dose X I000). Positive slope lines represent 
effect of increased immunizing doses at each challenge dose level. Negative slope lines repre- 
sent effect of increased challenge  doses  at each immunizing dose level. 
• Combined data, Table V a. 
regression equations for each sex were derived from the probits-survival data 
presented in Table V b. The two equations 
Females: ~" =  4.2855 -- 0.1925 X1 +  1.6554 X~  (5) 
Males:  ~" =  6.0331 -- 0.4602 Xi +  1.4548 X~  (6) 
where ~z =  expected probits-survival, X1 =  log-(challenge dose X  1000), and 
X, =  log-(immunizing dose X  1000), were derived using weighting coefficients 
and  corrected probits.  These equations represent probit-planes  as presented 
graphically in Fig.  1. 
The lack of parallelism evident upon visual inspection of the two probit- 
planes  was  confirmed by the  appropriate  x 2 test  (19).  The departure  from 
parallelism was found to exceed the 1 per cent level of significance. 246  GRADED IMMITNIZING AND CHALLENGING  DOSES 
The coefficients  of regression of probits-response on log-challenge dose for females and 
males, -0.1925  ±  0.0845 and -0.4602 =e 0.0836, respectively,  were found to differ signifi- 
cantiy as was expected  from the significant interaction CDL X S (Table VI). The coefficients 
of  regression  of  probits-response on  log-immunizing dose for  females and  males, 
1.4548 =e 0.1940 and 1.6554 -4- 0.1886, respectively, did not differ significantly. The differ- 
ence between the log-challenge dose and log-immunizing dose coefficients  exceeded the 0.1 
per cent level of significance. 
It is obvious from a comparison of the respective regression coefficients that 
graded  immunizing doses are  more effective than  graded  challenge doses in 
effecting a  dispersion of group responses. In Equation 5 the absolute value of 
the coefficient of X2 is 8.6 times that of X1. Thus a change of one unit in X2 
effects a change in ~" equal to that effected by a change in X1 of 8.6 units. As 
a practical illustration, by substitution of appropriate values of log-immunizing 
doses in Equation 5 it can be estimated that, with females, doubling the im- 
munizing dose produces a  difference in response equal to that produced by a 
388-fold increase in the challenge dose. With males (Equation 6) the difference 
is not as striking. The coefficient of X~ is 3.16 times that of X1. By substitution 
of appropriate values in Equation 6 it is estimated that doubling the immunizing 
dose produces a  difference in response equal to that produced by an 8.9-fold 
increase in challenge dose. Since estimation of these relative effects is based on 
the ratio of the regression coefficients, both of which are subject to considerable 
error, precision of the ratio is low. 
The Dosage-Response Relationship 
In the practical assay of typhoid vaccine by mouse protection tests a numeri- 
cal expression of potency is desirable. This usually is expressed as an ED~07 
value; the dosage estimated to effect response in 50 per cent of the group being 
tested. In practice it is assumed (or established) that the relationship between 
dosage and response is linear, and the dosage expected to effect a  50 per cent 
response is estimated by calculation or interpolation. 
It has been established  (15,  19)  that  the  dosage-mortality relationship  is 
essentially  linear  when percentage  mortality  is  transformed  to probits  and 
doses are transformed to logarithms. Although standard errors of ED60 values 
are dependent primarily upon the slope of the dosage-response regression line 
(20), these estimated values would be subject to further error it there was a 
systematic departure from linearity of the dosage-response relationship. 
In the analysis of variance presented in Table VI there was no evidence of 
any systematic departure from linearity in the relationship of probits-response 
to log-challenge dose and log-immunizing dose. The degree of departure from 
linearity with each variable is represented by the estimates  of the  quadratic 
The term LDso frequently is employed when dealing with dosage-mortality data.  In 
this presentation, the term ED60 is used throughout. H.  C,  13ATSON  247 
effects of challenge doses and immunizing doses, respectively. While the quad- 
ratic effect of challenge doses was greater than was that of immunizing doses, 
neither was significant. 
The practical importance of the greater significance of graded immunizing 
doses than of graded challenge doses as the basis of estimating potency is more 
readily apparent from a  consideration of  the standard errors of ED~0 values 
estimated from these data. As Bliss (20) has pointed out, these are standard 
errors of log-EDs0 values and are properly used only in the calculation of confi- 
dence limits which will bracket the true value in a  designated proportion of 
repeated trials. The lower and upper confidence limits differ unequally from the 
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FIG. 2.  Immunizing dose-survival relationships at three challenge dose levels. 
estimated EDs0 value, and thus it is difficult to compare directly the accuracy 
of EDs0 values when estimated under different experimental conditions. 
Miller and Tainter  (17)  have proposed an approximation to the standard 
error of an EDs0 value which is essentially an  average  standard  error.  This 
average standard error can be expressed as a percentage of the ED~0 and thus 
permits a direct comparison of the relative accuracy of EDs0 values estimated 
under different experimental conditions. 
Immunizing dose-survival curves  calculated separately for each  challenge 
dose level, ED~0 values, and average standard errors expressed as percentages 
of ED~0 values, are presented in Fig. 2. 
The parallelism of the regression lines in Fig. 2 indicates that the immunizing 
dose-survival relationship qualitatively is the same at each of the challenge dose 
levels tested. Furthermore, it is apparent that EDs0 values can be estimated 
from the immunizing dose-survival curve with comparable accuracy at any of 
the challenge dose levels. This is of importance in the routine potency testing 248  GP,  ADED  IMMUNIZING  AND  CHALLENGING  DOSES 
of typhoid vaccine, since any toxic effects due to large doses of either vaccine 
or challenge  organisms can be avoided to a considerable  degree without sacri- 
ficing precision  of the assay procedure by using small immunizing  doses and a 
correspondingly low challenge  dose. Furthermore,  it would appear possible to 
assay quite small  quantities  of antigenic  material such  as  frequently is  de- 
sirable in determining the distribution of such substances in fractionation and 
purification studies. 
Challenge  dose-mortality curves calculated separately for each immunizing 
dose level,  EDs0 values, and average standard errors expressed as percentage 
of the EDs0 values, where applicable, are presented in Fig. 3. 
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Only  the  challenge  dose-mortality curve at  the  immunizing  dose level of 
0.0125 ml. is strictly suitable for estimation of an ED60 value, since EDs0 values 
at the other immunizing  dose levels can  be estimated only by extrapolation. 
It is obvious, however, that the average standard errors of ED, values esti- 
mated from challenge  dose-mortality curves are so large that such values are 
relatively meaningless.  Also,  it appears that  the average standard errors ex- 
pressed as percentages  of EDs0 values may differ  markedly at the different 
immunizing  dose levels. 
DISCUSSION 
The data presented in this report reveal the marked variation in response ob- 
served in groups of mice even when they are subjected to the same experimental 
conditions of immunization aand challenge. The existence of this variation, or H.  C.  BATSON  249 
experimental error,  makes  difficult the  determination of the  significance of 
qualitative  and  quantitative  differences  in  response  to  different factors  or 
different levels of the same factor. Even marked differences in response between 
groups treated differently, such as in groups given different doses,  fail to  be 
statistically significant when there is a  comparable degree of variation in the 
response of groups treated alike. 
Statistical significance in experiments such as those reported here is not at- 
tained merely by reduction of experimental error through careful preparation 
of materials, selection of homogeneous test animals, and application of meticu- 
lous techniques. The source of a major portion of the variation is unknown and, 
accordingly, is not subject to direct control. Thus it becomes essential to insure 
that such variation is of random nature and, further, to employ valid methods 
for estimating this random variation independently of the effect of any of the 
experimental factors being studied. Failure to make these provisions inevitably 
results in the introduction of bias and the final conclusions may be subject to 
serious error. 
In these experiments, random distribution of variation of unknown origin 
was provided for, at least in part, by the methods of selecting and grouping of 
mice, location of groups in the test-animal room, and by following a  random 
order of injection. In the main, except for minor restrictions such as segregation 
of the sexes,  there was equal opportunity for any especially resistant or sus- 
ceptible mouse being assigned to any of the test groups. If any environmental 
or psychological effect resulted from the particular location of a group of mice 
in the test-animal room, all groups had equal opportunity of being assigned the 
location where exposure to the factor existed. Likewise, if there was any tend- 
ency for the challenge suspensions to gain or lose virulence during the injection 
period,  it  was  a  matter of chance which groups were  favored or  adversely 
affected. 
Provision of randomness does not necessarily insure that experimental error 
(variation within groups) will be decreased. In fact, it even may be greater than 
that obtained following a non-random procedure since the latter may result in 
the establishment of intragroup correlation. However, the random procedure 
does provide a basis for obtaining unbiased estimates of experimental error and 
thus the performance of significance tests is justifiable. 
The true significance of the effect of the sex of mice on their response to either 
graded immunizing doses or challenge doses is di~cult to determine from the 
data obtained in this study. It was found in the preliminary experiment with 
graded challenge doses that specifically immunized mice of both sexes  were 
essentially equally susceptible to S. typhosa, although possibly the females were 
slightly more susceptible to the smallest challenge dose (Table I a). It has been 
observed repeatedly in other experiments that in unprotected mice, females are 
slightly more susceptible than males. This tendency can be noted by comparing 250  GRADED  r~MUNIZING  AND  CHALLENGING  DOSt~S 
the deaths of unprotected mice of both sexes to a  challenge dose of approxi- 
mately 10 organisms as shown by the controls presented in Tables I a, III a, 
and V a. When these controls are combined it is seen that a total of 29 out of 
50 females died as compared with 23 out of 50 males. This difference is so small 
and the obvious potential error in administering challenge doses of this size is 
so great, that no significance could be attached to the difference if it were not 
observed repeatedly. 
In the preliminary experiment using graded immunizing doses and a constant 
challenge dose  (Table III a)  there was a  definite indication that females re- 
sponded better to immunization than did males. This difference was not sta- 
tistically significant, primarily as a result of the small number of groups em- 
ployed, but the tendency is evident. 
In the direct comparison of graded immunizing and challenge doses (Table 
V a), neither the main effect of sex nor the interaction between sex and im- 
munizing dose was significant, while the interaction between sex and challenge 
dose was significant at the 5 per cent level (Table VI). The explanation of these 
findings may be indicated from the results of the preliminary experiments as 
discussed above. The superior resistance of males to the challenge dose of 50 
organisms may be due to a lower native susceptibility. The superior resistance 
of females to the challenge dose of 20,000 organisms may be the result of an 
actual greater  response  to  immunization. This reversal  of resistance  at the 
different challenge dose levels would account for the significant interaction. If 
this explanation is correct, the significant interaction resulted primarily because 
of the particular range of immunizing and challenge doses employed and might 
not be observed if larger doses were used, Additional preliminary experiments 
have been conducted using larger immunizing and challenge doses and, while 
the data so far obtained are insufficient for adequate evaluation, a highly signifi- 
cant interaction between sex and challenge dose has not been observed. Further 
investigation on a more extensive scale of the existence of this interaction is 
contemplated and will be made the basis of a subsequent report. The mere fact 
that an interaction is statistically significant is no guarantee that it has any 
particular biological significance. As used here the term interaction is synony- 
mous with discrepance, and statistical significance may result merely from in- 
consistent responses to the various levels of one factor at all levels of the second 
factor. The error of estimation of probable response at any challenge dose level 
is exceedingly large  (Fig. 3),  and it is entirely possible that the discrepance 
observed is of an anomalous nature. Regardless of the true nature of the inter- 
action, it appears justifiable to conclude that the use of mixed sexes should be 
avoided; certainly whenever graded challenge doses are used to measure the 
degree of immune response. 
The superiority of graded immunizing doses over graded challenge doses as 
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with typhoid vaccine has been discussed in detail previously.  This superiority 
resulted primarily from (a) greater homogeneity in the response of groups of 
mice given the same immunizing dose than in groups given the same challenge 
dose, (b) a greater slope of the dosage-response curve and corresponding smaller 
standard errors  of estimated EDs0 values,  and  (c)  an effect apparently less 
dependent on the sex of mice employed. 
At each immunizing dose level, the response  (survival)  of mice was surpris- 
ingly independent of the size of challenge dose used. This suggests that effective 
resistance in the individual animal is the result of attainment of some threshold 
level of immunity and is not primarily a relative state. This observation further 
suggests that the greater protective effectiveness of increased immunizing doses 
is the result of stimulation of a greater proportion of the group to respond suffi- 
ciently to attain this threshold level. 
The use of average approximate standard errors of ED60 values estimated by 
the  Miller-Tainter method  (17)  is  somewhat  misleading.  This  method was 
selected because the errors could be expressed as percentages of the correspond- 
ing  EDs0 values and thus permitted a rough comparison  of  the accuracy of 
estimation of ED60 values under different experimental conditions. As Bliss (20) 
has pointed out these are standard errors of log-EDs0 values and are properly 
used only in the estimation of confidence limits which differ unequally from the 
ED60 values they bracket.  Confidence limits based on the average  standard 
errors approximated by  the Miller-Tainter method can be calculated as ED60 4- 
1.96 X  S.E.~Ds0  and differ considerably from the confidence limits calculated 
by the Bliss method. For example; the confidence limits of the immunizing dose 
EDs0 for the combined sexes challenged with 1000 organisms (Table V a) calcu- 
lated by the Miller-Tainter method are 0.0083 ml. and 0.0217 ml. These limits 
calculated by the Bliss method are 0.0098 ml. and 0.0266 ml. In either case the 
breadth of these limits clearly emphasizes the potential inaccuracy of estimated 
EDs0 values even when such estimates are based on data more extensive than 
commonly are available in the assay of immunogenic substances. 
Although directly comparable  data are  not available,  strongly suggestive 
evidence exists that the use of graded immunizing doses would be equally su- 
perior  to graded challenge doses in the assay of other antigenic substances. 
Thus, Sokhey (25), in an extensive study of the factors affecting the potency of 
plague vaccine, found that by employing an assay procedure  based on graded 
immunizing  doses and a  constant challenge  dose,  it was  possible  to  detect 
differences in the potency of products prepared from strains of different sources 
or subjected to different processing conditions. As mentioned previously,  Ken- 
drick et al.  (9) reported that assays of pertussis  vaccine were most reliable and 
reproducible when the graded immunizing doses method was employed. 
A similar advantage of the use of graded immunizing doses methods has been 
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ority of this method in determining the mouse protective  potency of anti- 
pneumococcal sera. Batson (27), in a direct comparison of the effects of graded 
serum doses and challenge doses in the titration of the mouse protective po- 
tencies of typhoid antisera, obtained similar results. In fact, when two serum 
solutions were prepared by dilution so that one contained twice as much original 
serum as the other, the experimentally determined relative potency of the two 
was 2.96 by the graded serum dose method and 27.5 by the graded challenge 
dose method. 
Finally, there is evidence that the superiority of the graded immunizing doses 
method holds for the biological assay of bacterial toxoids as well. Greenberg 
et al. (28) obtained quite reproducible results in the assay of tetanus toxoids by 
such a  procedure  and reported  they consistently were  able  to demonstrate 
differences in potency of toxoids from different manufacturers. 
SUMMARY 
A  study of the effect of graded immunizing doses of typhoid vaccine and 
graded challenge doses of S. typhosa in 5 per cent mucin on the degree of grada- 
tion of response  (survival or death)  elicited in successive groups of mice is 
reported. 
In the range of doses employed the effect of graded immunizing doses was 
markedly greater than was the effect of graded challenge doses. Statistically the 
difference exceeded the 0.1 per cent level of significance. 
It was concluded that the use of graded immunizing doses was preferable to 
the use of graded challenge doses as a  basis for the immunological assay of 
typhoid vaccine, since with the former there was obtained (a) a greater signifi- 
cance of differences in response of groups given graded doses even with smaller 
fold increments in successive doses,  (b) a greater slope of the dosage-response 
curve which permitted estimation of EDs0 values with smaller standard errors, 
and (c) an effect on response apparently less dependent on the sex of mice used. 
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